Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190

Showing 1-25 of 190 citing articles:

Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality
Jinjin Zhang, Xiang Dong, Guanghui Liu, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 64, Iss. 1, pp. 90-107
Open Access | Times Cited: 493
Cytokine Storm in COVID-19: Immunopathogenesis and Therapy
Christian Zanza, Tatsiana Romenskaya, A Manetti, et al.
Medicina (2022) Vol. 58, Iss. 2, pp. 144-144
Open Access | Times Cited: 240
Long COVID and its Management
Ho Cheng Koc, Jing Xiao, Weiwei Liu, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4768-4780
Open Access | Times Cited: 202
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e711-e720
Open Access | Times Cited: 175
Ivermectin for preventing and treating COVID-19
Maria Popp, Stefanie Reis, Selina Schießer, et al.
Cochrane library (2022) Vol. 2024, Iss. 3
Open Access | Times Cited: 154
Utilizing drug repurposing against COVID-19 – Efficacy, limitations, and challenges
Vineela Parvathaneni, Vivek Gupta
Life Sciences (2020) Vol. 259, pp. 118275-118275
Open Access | Times Cited: 121
Ivermectin for preventing and treating COVID-19
Maria Popp, Miriam Stegemann, Maria‐Inti Metzendorf, et al.
Cochrane library (2021) Vol. 2021, Iss. 10
Open Access | Times Cited: 89
Antibiotics for the treatment of COVID-19
Maria Popp, Miriam Stegemann, Manuel Riemer, et al.
Cochrane library (2021) Vol. 2022, Iss. 7
Open Access | Times Cited: 77
SARS-CoV-2 Infection and Associated Cardiovascular Manifestations and Complications in Children and Young Adults: A Scientific Statement From the American Heart Association
Pei‐Ni Jone, Anitha S. John, Matthew E. Oster, et al.
Circulation (2022) Vol. 145, Iss. 19
Open Access | Times Cited: 57
Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19
Sònia Garcia
Frontiers in Plant Science (2020) Vol. 11
Open Access | Times Cited: 55
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study
Rebecca Abbott, Alison Bethel, Morwenna Rogers, et al.
BMJ evidence-based medicine (2021) Vol. 27, Iss. 3, pp. 169-177
Open Access | Times Cited: 45
Hydroxychloroquine versus placebo in the treatment of non-hospitalised patients with COVID-19 (COPE – Coalition V): A double-blind, multicentre, randomised, controlled trial
Álvaro Avezum, Gustavo B.F. Oliveira, Haliton Alves de Oliveira, et al.
The Lancet Regional Health - Americas (2022) Vol. 11, pp. 100243-100243
Open Access | Times Cited: 34
Long covid patients travel abroad for expensive and experimental “blood washing”
Madlen Davies
BMJ (2022), pp. o1671-o1671
Open Access | Times Cited: 30
COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?
Wei Shen Ho, Ruirui Zhang, Yeong Lan Tan, et al.
Pharmacological Research (2022) Vol. 179, pp. 106201-106201
Open Access | Times Cited: 29
Mapping the viral battlefield: SARS-CoV-2 infection dynamics among healthcare workers in Brazil
Antonio Luiz Dal Bello Gasparoto, Samara Vilas-Bôas Graeff, Wellyngton Matheus de Souza Santiago, et al.
Human Resources for Health (2025) Vol. 23, Iss. 1
Open Access
Low dose of hydroxychloroquine is associated with reduced COVID-19 mortality: a multicenter study in China
Wu He, Ke Xu, Yongcui Yan, et al.
Frontiers of Medicine (2025)
Closed Access
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
Canhao Wu, Qin Xu, Huiyuan Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1523-1533
Open Access | Times Cited: 37
Drug pollution & Sustainable Development Goals
Saioa Domingo‐Echaburu, Liliana M. Dávalos, Gorka Orive, et al.
The Science of The Total Environment (2021) Vol. 800, pp. 149412-149412
Closed Access | Times Cited: 35
Management and Prevention of COVID-19 in Pregnancy and Pandemic Obstetric Care: A Review of Current Practices
Argyro Pountoukidou, Maria Potamiti-Komi, Vrisiis Sarri, et al.
Healthcare (2021) Vol. 9, Iss. 4, pp. 467-467
Open Access | Times Cited: 34
Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera
Vishal S. Patil, Vrushabh B Hupparage, Ajay P Malgi, et al.
Chinese Herbal Medicines (2021) Vol. 13, Iss. 3, pp. 359-369
Open Access | Times Cited: 33
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
Anne C. Regierer, Rebecca Hasseli, Martin Schäfer, et al.
RMD Open (2021) Vol. 7, Iss. 3, pp. e001896-e001896
Open Access | Times Cited: 32
Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare
Ella H. Leung, Jason Fan, Harry W. Flynn, et al.
Clinical ophthalmology (2022) Vol. Volume 16, pp. 1-13
Open Access | Times Cited: 24
A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
Yasser Mohamed, Yousra A. El‐Maradny, Ahmed K. Saleh, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113499-113499
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top